贝瑞基因：控股股东高扬因股票质押违约被动减持公司0.38%股份

Core Viewpoint - The controlling shareholder of Berry Genomics, Gao Yang, has been forced to reduce his stake in the company by 0.38% due to a stock pledge default, resulting in the forced sale of 1,331,583 shares by the creditor, Guosen Securities, between May 21 and May 22, 2025 [1]. Company Summary - Berry Genomics received a notification from its controlling shareholder, Gao Yang, regarding a stock pledge default [1]. - The forced sale involved 1,331,583 shares, which represents 0.38% of the company's total share capital [1].